Quarterly report pursuant to Section 13 or 15(d)

Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details)

v3.20.1
Marketable Equity Securities - Schedule of Investments in Marketable Equity Securities (Details) - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis $ 755,487 $ 755,487
Gross Unrealized Gains 815,420 1,005,825
Value 1,570,907 1,761,312
Common Stock    
Schedule Of Available For Sale Securities [Line Items]    
Cost Basis 755,487 755,487
Gross Unrealized Gains 815,420 1,005,825
Value $ 1,570,907 $ 1,761,312